Impact of a multidisciplinary approach involving clinical pharmacist on resolving drug related problems in chronic kidney patients: a prospective interventional study

[1]  P. Krolak-Salmon,et al.  Drug-related problems in older patients with advanced chronic kidney disease identified during pretransplant comprehensive geriatric assessment. , 2021, Nephrologie & therapeutique.

[2]  M. Price,et al.  Drug-Related Problems in Hospitalised Patients with Chronic Kidney Disease: A Systematic Review , 2021, Drug Safety.

[3]  Yong-fu Hang,et al.  Drug-related problems identified by clinical pharmacists in nephrology department of a tertiary hospital in China-a single center study. , 2021, Annals of palliative medicine.

[4]  Viswam Subeesh,et al.  Evaluation of prescribing practices and drug-related problems in chronic kidney disease patients: A cross-sectional study , 2020, Perspectives in clinical research.

[5]  Serkadis Debalke,et al.  Drug-Related Problems and Associated Factors among Patients Admitted with Chronic Kidney Disease at Jimma University Medical Center, Jimma Zone, Jimma, Southwest Ethiopia: A Hospital-Based Prospective Observational Study , 2019, International journal of nephrology.

[6]  P. Pávek,et al.  Analysis and management of drug related problems on a nephrology ward from a pharmacist's point of view. , 2019, Die Pharmazie.

[7]  A. Köttgen,et al.  Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study , 2019, Clinical kidney journal.

[8]  T. Salgado,et al.  Clinical pharmacy practice in the care of Chronic Kidney Disease patients: a systematic review , 2019, International Journal of Clinical Pharmacy.

[9]  D. Nyamu,et al.  Medication-related problems among adult chronic kidney disease patients in a sub-Saharan tertiary hospital , 2018, International Journal of Clinical Pharmacy.

[10]  D. Tripathy,et al.  KEYWORDS Chronic Kidney Disease (CKD), Haemodialysis, Glomerular Filtration Rate (GFR), End Stage Kidney Disease (ESKD), Kidney Disease Improving Global Outcomes (KDIGO) CKD Work Group. , 2018 .

[11]  M. Sancar,et al.  Drug related problems identified by clinical pharmacist at the Internal Medicine Ward in Turkey , 2018, International Journal of Clinical Pharmacy.

[12]  C. Ukwe,et al.  Evaluation of drug therapy problems among renal patients receiving care in some tertiary hospitals in Nigeria , 2017 .

[13]  F. Acheampong,et al.  Drug-related problems and their clinical interventions in a Ghanaian teaching hospital , 2016 .

[14]  F. Hobbs,et al.  Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis , 2016, PloS one.

[15]  L. Holst,et al.  Use of renal risk drugs in patients with renal impairment , 2015, International Journal of Clinical Pharmacy.

[16]  T. Chen,et al.  Drug-related problems and the clinical role of pharmacists in inpatient mental health: an insight into practice in Australia , 2014, International Journal of Clinical Pharmacy.

[17]  P. Mazzola,et al.  Impact of pharmacist interventions on drug-related problems and laboratory markers in outpatients with human immunodeficiency virus infection , 2014, Therapeutics and clinical risk management.

[18]  A. Jarab,et al.  Evaluation of the impact of pharmaceutical care service on hospitalized patients with chronic kidney disease in Jordan , 2013, International Journal of Clinical Pharmacy.

[19]  R. Lemmens‐Gruber,et al.  Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review , 2011, BMC nephrology.

[20]  T. Ecder,et al.  A population-based survey of Chronic REnal Disease In Turkey—the CREDIT study , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  N. Khan,et al.  Reduced Drug Use and Hospitalization Rates in Patients Undergoing Hemodialysis Who Received Pharmaceutical Care: A 2‐Year, Randomized, Controlled Study , 2009, Pharmacotherapy.

[22]  S. Mirkov.  Implementation of a pharmacist medication review clinic for haemodialysis patients. , 2009, The New Zealand medical journal.

[23]  A. Pai,et al.  Health‐related quality of life is maintained in hemodialysis patients receiving pharmaceutical care: A 2‐year randomized, controlled study , 2009, Hemodialysis international. International Symposium on Home Hemodialysis.

[24]  K. Viktil,et al.  The impact of clinical pharmacists on drug-related problems and clinical outcomes. , 2008, Basic & clinical pharmacology & toxicology.

[25]  G. Parthasarathi,et al.  Medication knowledge of hemodialysis patients and influence of clinical pharmacist provided education on their knowledge , 2007 .

[26]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[27]  K. Iseki,et al.  Analysis of drug prescription in chronic haemodialysis patients. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  H. Manley,et al.  The Clinical and Economic Impact of Pharmaceutical Care in End‐Stage Renal Disease Patients , 2002, Seminars in dialysis.

[29]  N. Mason,et al.  Chronic Hemodialysis Patients. Part II: Reducing Drug-Related Problems through Application of the Focused Drug Therapy Review Program , 1994, The Annals of pharmacotherapy.

[30]  Brenda R. Hemmelgarn,et al.  Notice , 2012, Kidney International Supplements.

[31]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[32]  V. Mil.  The Pharmaceutical Care Network Europe (PCNE) , 1997 .